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Abstract
Background
This study aimed to provide an overview of device-related complications occurring in individ-
uals with an upper or lower extremity amputation treated with a screw, press-fit or other type
of bone-anchored implant as well as interventions related to these complications.
Method
A systematic literature search was conducted in the MEDLINE, Cochrane, EMBASE, CINAHL
and Web of Science databases. The included studies reported on device-related complica-
tions and interventions occurring in individuals with bone-anchored prostheses. The outcomes
evaluated were death, infection, bone/device breakage, implant loosening, soft tissue compli-
cations, systemic events, antibiotic and surgical treatment. Subgroup analyses were per-
formed for the following groups: a) implant type (screw, press-fit and other types of implants)
and b) level of amputation (transfemoral, transtibial and upper extremity amputation).
Results
Of 309 studies, 12 cohort studies were eligible for inclusion, all of which had methodological
shortcomings and 12 studies were excluded due to complete overlap of patient data. Implant
infection were rare in certain transfemoral implants (screw: 2–11%, press-fit: 0–3%, Com-
press: 0%) but common in transtibial implants (29%). The same was observed for implant
loosening, in transfemoral (screw: 6%, press-fit: 0–3%, Compress: 0%), transtibial implants
(29%) as well as for upper extremity implants (13–23%). Intramedullary device breakage
were rare in transfemoral implants (screw: 0%, press-fit: 1%, Compress: unknown) but fre-
quent in individuals with transradial implants (27%) and absent in transtibial implants. Soft
tissue infections and complications were common and underreported in most articles.
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Conclusions
Major complications (e.g. implant infection, implant loosening and intramedullary device
breakage) are rare in transfemoral bone-anchored prosthesis and seem to occur less fre-
quently in individuals with press-fit implants. Minor complications, such as soft tissue infec-
tions and complications, are common but are substantially influenced by the learning curve,
implant design and surgical technique. Data for patients treated with a transtibial, upper
extremity or Compress implant are underreported, precluding definitive conclusions. There
is a need for either an international database to report on or a standard core set of complica-
tions as well as the need to follow classification systems that result in unequivocal data.
Introduction
The prevalence of individuals with extremity amputation is high and is only expected to
increase in the coming years.[1, 2] Large differences occur among different parts of the devel-
oped world depending largely on the prevalence of peripheral vascular disease, diabetes and
combat-related activities.[3] Most lower limb amputations are due to vascular disease, with the
incidence increasing annually, while upper limb amputation is most often the result of trauma.
[1, 2]
For the past six centuries, the rehabilitation of individuals with an upper or lower extremity
amputation has been achieved with socket-mounted prostheses.[4] Despite significant techno-
logical innovations to socket materials, liners and design,[5] individuals with an upper or
lower extremity amputation still exhibit significant socket-residuum interface problems, such
as skin irritation, pain and problems with prosthetic fixation.[6–10]
Approximately 56% of individuals with an upper and 80–95% with a lower extremity ampu-
tation use a prosthetic limb, with a rate of dissatisfaction with the prosthesis ranging from 18–
57%.[11–14] Skin problems are frequent in both upper and lower prosthetic limb users, ranging
from 34–63% of all users [8, 15–21], and falling occurs in roughly half of individuals with a
lower limb amputation due to poor proprioception and disbalance.[7, 22] Problems with pros-
thetic fixation and weight are more prevalent in individuals with upper extremity amputation.
[10, 12] These socket-residuum interface problems lead to prosthesis intolerance and abandon-
ment and have a severe impact on people’s activity levels and quality of life.[6, 9, 16, 23–25]
The only way to eliminate the socket-residuum interface and prevent the occurrence of these
problems is by directly attaching the prosthesis to the bone of the residual limb via the process of
osseointegration, which is defined as the direct connection of a ‘nonvital’ component incorpo-
rated in living bone.[26] This technique, originating from the field of dentistry in 1965, has been
well established for the treatment of the edentulous jaw for many years, demonstrating a 5 and
10-year survival of dental implants in mandibular bone of 98% and 95%, respectively.[27–29]
Bone-anchored hearing aids have been developed using this technique and have been applied on
a world–wide scale since 1977, with 5-year implant survival rates of 90–95%.[30] Since its first
introduction in 1990 in individuals with amputation, bone-anchored prostheses offer multiple
potential benefits for the treatment of selected individuals with amputations experiencing soc-
ket-related problems. These potential benefits include improved osseoperception, prosthesis
wearing time, a larger hip range of motion, and reduced oxygen consumption while walking,
[31–36] which are associated with an improved mobility level, walking ability and overall quality
of life.[32, 34, 37, 38] Since 1990,[26] bone-anchored prostheses have been used predominantly
in individuals with a non-vascular cause of amputation, but small series have already been
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published showing the results of osseointegration treatment in individuals with stable vascular
disease.[39, 40]
Several certified bone-anchored implants are currently available for humans: the Osseointe-
grated Prosthesis for the Rehabilitation of Amputees (OPRA),[32, 41–43] which is a screw
implant made of titanium alloy. Also currently available are the Integral Leg Prosthesis (ILP, pre-
viously known as Endo-Exo Femur/Tibia Prosthesis; EEFP/EETP)[34, 44–50] and the Osseoin-
tegration Group of Australia-Osseointegration Prosthetic Limb (OGAP-OPL);[43], which are
both press-fit implants, made of cobalt-chromium-molybdenum or titanium alloy respectively.
Several newer systems are currently under development of which some have reached the stage of
clinical experiments in humans.[51, 52] Initially, bone-anchored prostheses have been implanted
in a two-stage procedure similar to their dental pre-ancestors, with an interval of six months and
six to eight weeks for the screw and press-fit implants, respectively.[41, 43, 46] A protocol for
single stage implantation of an osseointegrated prosthesis has recently been published, for which
results regarding safety and efficacy remain to be evaluated.[53]
Over the last few years, multiple clinical studies have been performed to evaluate complica-
tions and the survival of bone-anchored prostheses for the treatment of individuals with upper
and lower extremity amputation. At present, no systematic evaluation of complications after
upper extremity amputation has been published. Reviews by van Eck et al.[54], Hebert et al.[55]
and Al Muderis et al.[56] evaluated the complication rate in individuals restricted to lower
extremity bone-anchored prosthesis. However, none of these reviews stratified the complication
rate at the amputation level. Furthermore, van Eck et al. and Al Muderis et al. did not stratify
for the type of bone-anchored prosthesis, resulting in limited clinical usability. The latter is
important because the fixation principle of these implants are different because they are being
developed for dentistry (screw) and orthopedic surgery (press-fit).[57, 58] Another limitation
was that insight in the level of overlap in participants in the included studies was not [54, 56] or
insufficiently provided [55] despite the often partial and occasionally even total overlap of the
embedded cohort of participants.
Therefore, the two aims of this study were to provide (a) a stratified overview of device-
related complications in individuals with a lower or upper extremity amputation treated with a
screw, press-fit or other type of bone-anchored prostheses and (b) a stratified overview of the
complication-related interventions that occur in these individuals treated with bone-anchored
prosthetics.
Methods
Design
This systematic review of published, peer-reviewed articles with original data was conducted
following the guidelines of the PRISMA statement.[59] The initial review protocol has been
registered in the PROSPERO database.[60] The focus of the initial review protocol was screw
or press-fit bone-anchored prostheses, nonetheless upon writing we decided to include other
types of bone-anchored prostheses following the classification by Thesleff et al. [52]
Data collection
A comprehensive search was performed by the second author (RL) on 8 January 2018 in MED-
LINE (accessed via PubMed), Cochrane Central Register of Controlled Trials, Embase (accessed
via OvidSP), CINAHL, Web of Science and System for information on Grey Literature. Several
combinations of terms and expressions were used, including both MeSH and free text terms.
The final search string included (osseointegrat OR osseo-integrat OR bone-anchored
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prosthe) AND (amput). No date limits or geographical restrictions were used. Search strings
for each database are provided in S1 Appendix.
Eligibility criteria
The eligibility of studies was independently assessed by RA and RL. We included articles of ran-
domized controlled trials, controlled clinical trials and prospective and retrospective observa-
tional studies (including before-after, cohort and case–control studies). Articles were included
if they reported device-related complications and/or complications related to interventions in
people with an upper and/or lower extremity amputation treated with bone-anchored prosthe-
ses. We excluded studies that were not in the English, Dutch or German language. Furthermore,
we excluded studies that presented completely duplicated data, studies that presented no origi-
nal data (e.g., systematic reviews) and studies without having a full text. The individual studies
embedded in systematic reviews were screened using the same eligibility criteria.
Study selection
Study selection was completed in two phases by two reviewers (RA, RL) independently. Dur-
ing the first phase, titles and abstracts of studies retrieved using the search strategy were
screened to identify studies potentially meeting the inclusion criteria. The full text of these
potentially eligible studies were retrieved and independently assessed for eligibility by both
reviewers during the second phase. Additionally, a manual search of the reference list of the
included articles was performed (Fig 1). In case of disagreement in any screening stage, con-
flicts were resolved in a consensus meeting. Reasons for exclusion of the title and abstract of
the reviewed articles are outlined in S2 Appendix. If articles presented a partial overlapping
cohort of participants, the authors were contacted to provide source data aiming to include
only unique cohorts of participants. If no response was obtained after one reminder, we
included all involved articles to avoid the loss of relevant data. If the cohorts of participants
completely overlapped, the study with the largest cohort was included.
Data extraction and analysis
Data extraction was performed by two authors independently (RA and RL). Again, if any dis-
crepancies occurred, a consensus was provided in discussion. Data were extracted using a stan-
dardized form and included authors, publication year, study location, follow-up period, study
design, time interval of inclusion, participant demographics, type of intervention (single or
two stage surgery), type of implant (screw, press-fit or other), device-related complications
(death, infection, bone fracture, device breakage, implant loosening, stoma hypergranulation,
stoma redundant tissue and systemic events) and complication-related interventions (antibi-
otic use and surgical treatment). If possible, the level of infection was categorized using a classi-
fication system for infection based on clinical and radiographic signs, which was published by
Al Muderis et al. Table 1.[61] If an article only described specific complications, all other com-
plications were scored as “unknown”. Complications were scored as a percentage of the total
individuals in which they occurred. If enough unique homogeneous studies were included
with overlapping follow-up time points, a meta-analysis was conducted to pool the incidence
of device-related complications and complication-related interventions. Outcomes were ana-
lyzed separately for short-term (less or equal than one-year), mid-term (two to five year) and
long-term (equal or more than five-year) follow-up. If the necessary data were available, sub-
group analyses were performed for the following groups: a) implant type (screw, press-fit or
other) and b) level of amputation (transfemoral, transtibial and upper extremity amputation).
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Methodological quality
The methodological quality of the included articles was independently assessed by two
reviewers (RA and RL), after which disagreements were discussed in consensus meetings.
In the case of persistent disagreement, a third reviewer was consulted to mediate (TH).
The methodological quality (risk of bias) was scored using the Effective Public Health
Practice Project (EPHPP) Quality Assessment Tool for Quantitative Studies.[62, 63] The
EPHPP was chosen because we anticipated retrieving different types of non-randomized
Fig 1. Flowchart for included studies.
https://doi.org/10.1371/journal.pone.0201821.g001
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observational studies. The EPHPP Quality Assessment Tool assesses six aspects of meth-
odology: (1) selection bias, (2) study design, (3) control of confounders, (4) blinding of
participants and investigators, (5) data collection tool validity and reliability, and (6) pro-
portion of withdrawals and drop-outs. Every study was assessed using the tool, and the
studies were rated as “strong”, “moderate” or “weak” with respect to the above-mentioned
aspects using standard criteria. [62, 63] Combining the ratings of all six aspects of method-
ology resulted in an overall rating of quality (global rating), with studies classified as hav-
ing “strong” methodology when no aspects were rated weak, “moderate” when only one
aspect was rated weak and “weak” when multiple aspects of methodology were rated weak.
[62, 63] Inter-rater agreement on aspects of methodology was measured with a linear,
weighted Cohen’s Ƙ coefficient.[64] Values were classified as follows: 0.41–0.60: fair
agreement; 0.61–0.80: good agreement; 0.81–0.92: very good agreement; 0.93–1.00: excel-
lent agreement.[65]
Results
Selected studies
We identified 309 unique articles in the search and 1 from screening references (Fig 1). Twenty-
four articles met our in-and exclusion criteria of which 12 articles were excluded because the
cohorts of participants overlapped completely.[34, 38, 41, 42, 44–46, 48, 66–69] The 12 remain-
ing eligible articles [43, 47, 49–51, 61, 70–75] described a total of 537 individuals with a lower
and 67 individuals with an upper limb amputation. All individuals were treated with bone-
anchored prostheses in eight different centers worldwide, but some articles presented partial
overlapping cohorts of participants. The three articles of the Australian center had overlapping
data in the period from 2011–2013 and 2013–2014,[43, 61, 70] the articles of the German center
had an overlap in data in the period from 2003–2013,[47, 49, 50] the articles of the Swedish cen-
ter regarding individuals with upper extremity amputation had an overlap in the period 1995–
2010 [71, 75] and the article by Tillander et al. from 2010 had an unclear interval of inclusion.
[74] A Gantt chart was made to provide a better overview of the amount of overlap in data
between studies (Fig 2). Due to Tillander et al. [73] reporting on all the individuals with transfe-
moral amputation which were also partly reported on by Li et al. [71] we only included the indi-
viduals with an upper extremity amputation from the article by Li et al.
Table 1. Classification of infection.
Level of Severity Symptoms and Signs Treatment Grade
Low-grade soft tissue
infection
Cellulitis with signs of inflammation (redness, swelling, warmth, stinging pain, pain that increases
on loading, tense)
-Oral Antibiotics 1A
-Parenteral Antibiotics 1B
-Surgical Intervention 1C
High-grade soft tissue
infection
Pus collection, purulent discharge, raised level of C-reactive protein -Oral Antibiotics 2A
-Parenteral Antibiotics 2B
-Surgical Intervention 2C
Bone infection Radiographic evidence of osteitis (periosteal bone reaction), radiographic evidence of osteomyelitis
(sequestrum and involucrum)
-Oral Antibiotics 3A
-Parenteral Antibiotics 3B
-Surgical Intervention 3C
Implant failure Radiographic evidence of loosening -Parenteral antibiotics,
explantation
4
https://doi.org/10.1371/journal.pone.0201821.t001
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Study characteristics
Table 2 provides the characteristics of the included articles. The 12 articles presented six retro-
spective cohort studies,[47, 49, 50, 70, 73, 75] three prospective cohort studies [43, 61, 74] and
three cohort studies with an undefined design.[51, 71, 72] Three articles described two separate
patient cohorts based on the amputation level or implant type.[47, 49, 50] We stratified our
results by the number of cohorts described, resulting in a total of 15 cohorts. One of these
cohorts was described by Tillander et al.[74], who used a combination of individuals with
lower and upper extremity amputation and thus the outcome of this cohort will be mentioned
separately to avoid clouding the overall results. The follow-up period of all cohorts ranged
from 1 to 288 months no study was included with a fixed follow-up. The most common cause
of amputation was trauma. One article presented cohort data from two centers in different
countries.[61] Surgery was performed in eight centers in six countries: Australia [43, 61, 70],
Germany [47, 49, 50], the Netherlands [61], Sweden [71, 73–75], the United Kingdom [72]
and the USA [51]. The OPRA screw implant was used in Sweden and the United Kingdom,
the ILP/OPL press-fit implant was used in Australia, Germany and the Netherlands and the
Compress implant was used in the USA.
Of the 604 individuals in the 15 included cohorts, 206 were treated with a screw implant, 387
were treated with a press-fit implant and 11 were treated with the Compress implant. A total of
522 individuals were treated with a transfemoral amputation (screw: 139, press-fit: 373, Com-
press: 10), 15 with a transtibial amputation (screw: 1, press-fit 14) and 67 individuals with an
upper extremity amputation (screw: 66, press-fit: 0, Compress: 1), of which 40 had a transhumeral
amputation (screw: 39, Compress: 1), 14 a transradial amputation and 13 a thumb amputation.
The mean age at the time of implantation surgery was 45, 47 and 48 years in individuals
treated with a screw, press-fit or Compress implant respectively. The mean time from primary
amputation to implantation was 10.3 and 12.3 years for individuals treated with a screw and
press-fit implant, respectively and was not described in the article regarding the Compress
implant.
Fig 2. Gantt chart of overlapping data.
https://doi.org/10.1371/journal.pone.0201821.g002
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Table 2. Study characteristics.
Authors (years)
Study location
Study design Time interval
inclusion of
patients
Mean follow-
up (months)
± SD
(median)
[range]
Participants (n),
Implants, Sex (M/
F), Level of
amputation
Cause of
amputation (%)
Mean age
(years) at
surgery ±SD
(median)
[range]
Mean time
(years) from
primary
amputation to
surgery SD
(median) [range]
Type of
Intervention: type of
implant / type of
alloy / type of
surgery(1-step,
2-step)
Al Muderis et al.,
Australia (2017)
[70]
Retrospective
cohort
December
2013 to
November
2014
14 ± ? (?) [10–
30]
N = 22 (22
implants), (16 M, 6
F), 22 uni-TF
Trauma (73),
Tumour (18),
Infection (9)
46 ± ? (?)
[20–67]
? ± ? (?) [?] Press-fit: OPL /
(titanium / 1-step
Li et al., Sweden
(2017) [71]
Cohort TR: 1990 to
2017, Thumb:
1990 to 2014,
TH: 1995 to
2010
TR ? ± ? (?)
[?], Thumb ?
± ? (?) [?], TH
? ± ? (96) [24–
228]
N = 42 (43
implants), (TR: 10
M, 1 F; TH: 10 M, 3
F; Thumb: ?), 10 uni
TR, 1 bi-TR, 13 uni-
thumb, 18 uni-TH
TR: ?, Thumb:
Trauma (85),
Tumour (15),
TH: ?
? ± ? (?) [?] ? ± ? (?) [?] Screw: OPRA /
Titanium / 2-step
McGough et al.,
USA (2017) [51]
Cohort 2012 to 2017 ? ± ? (?) [?] N = 11 (11
implants), (10 M, 1
F), 10 uni-TF, 1 uni-
TH
Trauma (55),
Tumour (36),
Infection (9)
47 ± ? (?)
[26–68]
? ± ? (?) [?] Compress / ?? /
1-step (n = 6) and
2-step (n = 5)
Tillander et al.,
Sweden (2017)
[73]
Retrospective
cohort
May 1990 to
January 2010
95 ± ? (74)
[18–235]
N = 96 (102
implants), (60 M, 36
F), 90 uni-TF, 6 bi-
TF
Trauma (71),
Tumour (20),
Ischemia (5),
Infection (5),
Other (1)
43 ± ? (?)
[19–65]
11.5 ± ? (?) [<1–
44]
Screw: OPRA /
Titanium / 2-step
Al Muderis et al.,
Australia, The
Netherlands
(2016) [61]
Prospective
cohort
May 2009 to
May 2013
? ± ? (34)
[range 24–71]
N = 86 (91
implants), (65 M, 21
F), 76 uni- TF, 5 bi-
TF
Trauma (76),
Tumour (13),
Infection (9),
Congenital (1),
Other (1)
48 ± 14 (?)
[25–81]
16 ± 14 (?) [?] Press-fit: ILP/
Cobalt-chromium-
molybdenum/2-step
Al Muderis et al.,
Australia (2016)
[43]
Prospective
cohort
March 2011 to
June 2014
22 ± ? (?)
[range 1-?]
N = 50 (50
implants), (34 M, 16
F), 50 uni-TF
Trauma (64),
Tumour (16),
Infection (10),
Congenital (4),
Blast injury (6)
48 ± ? (?)
[24–73]
? ± ? (?) [2–65] Press-fit: ILP
(Cobalt-chromium-
molybdenum)/OPL
(titanium)/2-step
Aschoff et al.,
Germany (2016)
[47]
Retrospective
cohort
January 2003
to December
2014
? ± ? (?) [?] N = 86 (94
implants), (68 M, 18
F), 73 uni-TF, 6 bi-
TF, 5 uni-TT, 2 bi-
TT
Trauma (77),
Tumour (8),
Other (15)
[17–76] ? ± ? (?) [?] Press-fit: EEFP
+ EETP = ILP =
cobalt chrome
molybdenum/2-step
Authors (years),
Study location
Study design Time interval
inclusion of
patients
Mean follow-
up (months)
± SD
(median)
[range]
Participants (n),
Implants, Sex (M/
F), Level of
amputation
Cause of
amputation (%)
Mean age
(years) at
surgery ±SD
(median)
[range]
Mean time
(years) from
primary
amputation to
surgery SD
(median) [range]
Type of
Intervention: type of
implant / type of
alloy / type of
surgery(1-step,
2-step)
Juhnke et al.,
Germany (cohort
1) (2015) [50]
Retrospective
cohort
January 1999
to December
2008
74 ± 31 [6–
144]
N = 30 (31
implants), (25 M, 5
F), 29 uni-TF, 1 bi-
TF
Trauma (77),
Tumour (17),
Infection (3),
Other (3)
46 ± 13 [17–
69]
11 ± ? (?) [?] Press-fit: ILP design
A and B/Cobalt-
chromium-
molybdenum/2-step
Juhnke et al.,
Germany (cohort
2), (2015) [50]
Retrospective
cohort
January 2009
to December
2013
32 ± 18 (?)
[1–59]
N = 39 (42
implants), (31 M, 8
F), 36 uni-TF, 3 bi-
TF
Trauma (72),
Tumour (5),
Infection (5),
Burn (3), Other
(15)
45 ± 12 (?)
[24–76]
11 ± ? (?) [?] Press-fit: ILP design
C/Cobalt-
chromium-
molybdenum/2-step
Juhnke et al.,
Germany (2015)
[49]
Retrospective
cohort study
August 1999
to December
2013
? ± ? (?) [?] N = 74 (80
implants), (59 M, 15
F), 63 uni-TF, 4 bi-
TF, 5 uni-TT, 2 bi-
TT
Trauma (76),
Tumour (9),
Other (15)
46 ± ? (?)
[17–76]
11 ± ? (?) [?] Press-fit: EEFP and
EETP = ILP/?/2-step
(Continued)
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In each article if possible, loss to follow-up was determined by calculating the amount of
individuals lost to follow-up that were not subdivided in any other category of complications.
Methodological quality assessment
The inter-rater agreement of the assessment expressed as ƙ was 0.93±0.04, with 96% inter-
rater agreement between the two reviewers on the ratings of the individual domains of meth-
odological quality. The most common shortcomings of the studies were failure to blind asses-
sors and participants, lack of adjustment for confounding variables and limited validity or
reliability of the data collection methods. The few disagreements about domain errors were
due to errors in comprehension or differences in interpretation of the methodological quality
criteria. Disagreements were resolved in a consensus meeting. Scores for the six domains of
methodological quality and the global EPHPP scores are presented in table 3.
Table 2. (Continued)
Tsikandylakis
et al., Sweden
(2014) [75]
Retrospective
cohort
1995 to 2010 ? ± ? (96) [24–
288]
N = 18 (18
implants), (16 M, 2
F), 18 uni-TH
Trauma (89),
Tumour (11)
42 ± ? (?)
[19–69]
9 ± ? (?) [2–33] Screw: OPRA/
Titanium/2-step
Tillander et al.,
Sweden (2010)
[74]
Prospective
cohort
January 2005
to June 2005
36 ± ? (?) [?] /
Time BAP to
inclusion: 54
± ? (?) [3–
132]
N = 39 (45
implants), (21 M, 18
F), 31 uni-TF, 1 bi-
TF, 2 uni-TR, 1 bi-
TR, 3 uni-TH, 1
uni-TT
Trauma (?),
Tumour (?)
49 ± ? (?)
[28–74]
? ± ? (?) [?] Screw: OPRA/
Titanium/2-step
Sullivan et al.,
United kingdom
(2003) [72]
Cohort 1997 ? ± ? (?) [?] N = 11 (11
implants), (? M, ?
F), 11 TF
? ? ± ? (?) [?-?} ? ± ? (?) [?-?} Screw: OPRA/
Titanium/2-step
SD = standard deviation, M = Male, F = Female, OPRA = Osseointegrated Prosthesis for the Rehabilitation of Amputees, OGAAP = The Osseointegration Group of
Australia Accelerated Protocol, TF = Transfemoral, TT = Transtibial, TH = Transhumeral, TR = Transradial, Uni- = Unilateral, Bi- = Bilateral, ILP = Integral Leg
Prosthesis, OPL: Osseointegration prosthetic limb (OGAP-OPL), EEFP = Endo-exo Femur Prosthesis, EETP = Endo-exo Tibia Prosthesis, BAP = Bone-anchored
prosthesis, ? = Unknown/unclear.
 With exclusion of individuals with TF amputation due to the overlap with Tillander et al.[73].
https://doi.org/10.1371/journal.pone.0201821.t002
Table 3. Methodological quality assessment ratings based on the Effective Public Health Practice Project tool for quantitative studies.
Authors (year) Selection bias Study design Confounders Blinding Data collection Withdrawals and drop-outs Global rating
Al Muderis et al. (2017)[70] Moderate Moderate Weak Weak Weak Strong Weak
Li et al. (2017)[71] Moderate Moderate Weak Weak Weak Weak Weak
McGough et al. (2017)[51] Moderate Moderate Weak Weak Weak Weak Weak
Tillander et al. (2017)[73] Moderate Moderate Weak Weak Weak Strong Weak
Al Muderis et al. (2016)[61] Moderate Moderate Weak Weak Weak Strong Weak
Al Muderis et al. (2016)[43] Moderate Moderate Weak Weak Weak Strong Weak
Aschoff et al. (2016)[47] Moderate Moderate Weak Weak Weak Weak Weak
Juhnke et al. (2015)[50] Moderate Moderate Weak Weak Weak Weak Weak
Juhnke et al. (2015[49]) Moderate Moderate Weak Weak Weak Weak Weak
Tsikandylakis et al. (2014)[75] Moderate Moderate Weak Weak Weak Weak Weak
Tillander et al. (2010)[74] Weak Moderate Weak Weak Weak Strong Weak
Sullivan et al. (2003)[72] Moderate Moderate Weak Weak Weak Weak Weak
https://doi.org/10.1371/journal.pone.0201821.t003
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Synthesis of results/meta-analysis
Because many cohorts partially overlapped, we could not conduct a meta-analysis. None of the
contacted authors were able to provide source data. Due to the heterogeneity in follow-up time-
points, we could not stratify the outcomes in short-, mid- and long-term outcomes. We stratified
the outcomes of individual studies into two categories: a) implant type (screw, press-fit and
other) and b) level of amputation (transfemoral, transtibial and upper extremity amputation).
Results of individual studies
Table 4 presents the device-related complications, and table 5 presents the complication-
related interventions occurring in individuals with bone-anchored prostheses.
Infection. The occurrence of infection was reported in 11 out of 15 cohorts (73%).[43, 49–
51, 61, 70, 73–75] The infection rate ranged from 23–49% in individuals treated with screw
implants compared with 0–77% in individuals treated with press-fit implant and 0% in individu-
als treated with the Compress implant. Soft tissue infections in the skin-penetrating area (Grade
1–2) occurred in 28% and 0–57% of individuals treated with screw and press-fit implants, respec-
tively. Bone infection (Grade 3) occurred in 5–13% and 0% of individuals treated with screw and
press-fit implants, respectively. Infections resulting in implant loosening (Grade 4) occurred in
8–11% and 3–29% of individuals treated with screw and press-fit implants, respectively.
Examination of infections rates in relation to amputation level revealed a rate of infection
ranging from 0–77% in individuals with transfemoral amputation treated with press-fit implants
and 44% in individuals with upper extremity amputation. The rate of infection in individuals
with transfemoral amputation treated with screw implants or individuals with transtibial ampu-
tation was unkown. The rate of soft tissue infections (Grade 1–2) ranged from 0–57% in individ-
uals with transfemoral amputation treated with press-fit implants and there was a rate of 28% in
individuals with upper extremity amputation. There was no reported rate in individuals with
transfemoral amputation treated with screw implants or individuals with transtibial amputation.
Bone infection (Grade 3) occurred in 13% of individuals with transfemoral amputation treated
with screw implants and 6% of individuals with upper extremity amputation. There was no
reported rate in individuals with transfemoral amputation treated with press-fit implants or in
individuals with transtibial amputation. Implant loosening due to infection (Grade 4) occurred
in 0–11% of individuals with transfemoral amputation (screw-fit: 11%, press-fit: 0–3%), 29% of
individuals with transtibial amputation and 11% of individuals with upper extremity amputation,
all of which being individuals with transhumeral amputation.
The article by Juhnke et al.[50] was the only one reporting infection rates before and after
adaptation of surgical technique and implant design and presented a decrease in infection
rates from 77% to 0% in press-fit transfemoral implants. The article by Tillander et al.[74] was
the only one to report the incidence of infection in individuals attending a scheduled or emer-
gency visit who were surveyed at inclusion and three years later. The reported incidence of
infection was 23 and 49% (among which 8% implant loosening) at inclusion and three years
later, respectively, among a cohort of individuals with an upper- and lower-extremity amputa-
tion treated with screw implants.
Peri-prosthetic bone fracture. The incidence of peri-prosthetic bone fracture was
described in nine of 15 cohorts (60%) with an incidence of 0% in individuals treated with a
screw implant, 0–10% in individuals treated with a press-fit implant and 18% in individuals
treated with the Compress implant.[43, 47, 49–51, 61, 70, 75] Three articles reported the cause
of bone fracture which were falls in all studies.[43, 51, 61] All reported peri-prosthetic bone
fractures occurred in individuals with press-fit transfemoral bone-anchored implants. No frac-
tures occurred in individuals with upper extremity bone-anchored implants and no data
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Table 4. Device-related complications.
Autdors
(years)
Implant
type/ Level
of
amputation
Loss to
follow-up
(%) (reason)
Un-
eventful
course
(%)
Infection (%)
(grade (% of
patients))
Bone
fracture
(%)
Device
breakage,
(intr.,
DCA/abut.
(% of
total))
Implant
loosening
(%)
Stoma
hyper-
granulation
(%)
Stoma
redundant
tissue (%)
Otder soft
tissue
complications
(%)
Systemic
events
(MI/PE)
(%)
Transfemoral
Tillander et al.
(2017) [73]
Screw 2 (50 DU
death, 50 ?)
? ? (grade 1–2:
?, grade 3:
13, grade 4:
11)
? ? ? ? ? ? ?
Sullivan et al.
(2003) [72]
Screw ? ? ? ? 45 (abut.:
100)
? ? ? ? ?
Al Muderis
et al. (2017)
[70]
Press-fit 5 (DU
death)
? 57 (grade 1:
48, grade 2:
10)
0 0 0 ? ? ? ?
Al Muderis
et al, (2016)
[61]
Press-fit ? 36 34 (grade 1:
29, grade 2:
5)
3 31 (Intr.: 6
(2% of
patients),
DCA: 94
(29% of
patients)
1 20 16 ? ?
Al Muderis
et al. (2016)
[43]
Press-fit 6 (100 DU
death)
32 42 (?) 8 2 (intr.:
100)
2 ? 14 ? ?
Aschoff et al.
(2016) [47]
Press-fit ? ? ? 8 1 (Intr.:
100)
0 ? ? ? ?
Juhnke et al.
(cohort 1)
(2015) [50]
Press-fit ? 20 77 (grade
1–2: ?, grade
3: ?, grade
4:3)
10 3 (?) ? ? ? ? ?
Juhnke et al.
(cohort 2)
(2015) [50]
Press-fit ? 87 0 (-) 5 0 3 3 3 3 (fistula) ?
Juhnke et al.
(2015) [49]
Press-fit ? ? ? (grade 1–2:
?, grade 3: ?,
grade 4: 3%)
10 ? ? ? ? ? ?
McGough
et al. (2017)
[51]
Compress ? 73 0 18 ? 0 ? 9 ? ?
Authors
(years)
Implant
type/ Level
of
amputation
Loss to
follow-up
(%) (reason)
Un-
eventful
course
(%)
Infection (%)
(grade (% of
patients))
Bone
fracture
(%)
Device
breakage,
(intr.,
DCA/abut.
(% of
total))
Implant
loosening
(%)
Stoma
hyper-
granulation
(%)
Stoma
redundant
tissue (%)
Other soft
tissue
complications
(%)
Systemic
events
(MI/PE)
(%)
Transtibial
Aschoff et al.
(2016) [47]
Press-fit ? ? ? ? ? 29 ? ? ? ?
Juhnke et al.
(2015) [49]
Press-fit ? ? ? (grade 1–2:
?, grade 3: ?,
grade 4:
29%)
? ? ? ? ? ? ?
Upper
extremity
(Continued)
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reported on the incidence of fractures in individuals with transfemoral amputation treated
with screw implants or individuals with transtibial bone-anchored implants.
Device breakage. The incidence of device breakage were mentioned in eight of 15 cohorts
(53%) and subdivided in fractures of the intramedullary implant, of the abutment (screw) and
of the dual cone adaptor (press-fit).[43, 47, 50, 61, 70–72] Device breakage occurred in 27–
45% and 0–31% of individuals treated with screw and press-fit implants, respectively. These
device breakages were of the abutment and intramedullary part in screw implants (transfe-
moral: 100% abutment, transradial: 100% intramedullary component) and mostly breakages of
the dual cone adapter in press-fit implants (up to 94%). Device fractures were not reported in
the cohort treated with the Compress implant.[51]
No intramedullary device breakages were reported in individuals with transfemoral ampu-
tation treated with screw implants, while intramedullary device breakages occurred in, on
average, 1% of individuals with transfemoral amputation treated with press-fit implants. No
device breakages were reported in individuals with transtibial bone-anchored prostheses.
There was an incidence of intramedullary device breakage of 27% in individuals with transra-
dial screw implants. The article by Juhnke et al.[50] did not specify the part of the device in
which a breakage occurred.
Implant loosening. The incidence of implant loosening of the bone-anchored implants
was reported in nine of the 15 cohorts (60%).[43, 47, 50, 51, 61, 70, 71, 74] It ranged from
3–23% and 0–29% in individuals treated with screw and press-fit implants, respectively. No
implant loosening occurred in individuals treated with the Compress implant.
The rate of implant loosening was not described in individuals with transfemoral amputa-
tion treated with screw implants and was 0–3% in those treated with press-fit implants.
Implant loosening occurred in up to 29% of individuals with transtibial amputation treated
with press-fit implants and in 13% and 23% of individuals with transhumeral and thumb
amputation respectively, treated with screw implants. Implant loosening was not reported in
individuals with transradial amputation. All implants (3%) that presented with loosening in
the cohort reported by Tillander et al.[74] were transfemoral screw implants.
Table 4. (Continued)
Li et al., (2017)
[71]
Screw
(Mixed
upper
extremity)
TR: ?,
Thumb: ?,
TH: 11 (at 2
year FU)
TR: ?,
Thumb:
46, TH: ?
? ? TR: 27
(Intr. 100),
Thumb: ?,
TH: ?
TR: ?,
Thumb:
23, TH: 13
? ? ? ?
Tsikandylakis
et al. (2014)
[75]
Screw 0 ? 44 (grade 1:
28, grade 3:
6, grade 4:
11)
0 ? ? 44 ? ? ?
Tillander et al.
(2010) [74]
Screw
(Mixed
upper/lower
extremity)
5 (100
unspecified
NM)
? Inclusion: 23
(grade
1–2:18, grade
3:5), FU: 49
(grade 1–2:
30, grade
3:11, grade 4:
8)
? ? 3 (100:
TF)
? ? ? ?
Grading of infection = Grade 1: Superficial soft tissue, Grade 2: Deep soft tissue, Grade 3: Bone infection, Grade 4: Implant infection. DCA = Dual cone adaptor, Intr. =
Intramedullary device, Abut. = Prosthetic abutment, MI = Myocardial infarction, PE = Pulmonary embolism, TF = Transfemoral, TT = Transtibial,
TH = Transhumeral, DU = Device-unrelated, DR = Device-related, Loose. = Implant loosening, No-S2 = Not yet after Surgery 2, NM = Non-medical, FU: follow-up
https://doi.org/10.1371/journal.pone.0201821.t004
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Soft tissue complications. Soft tissue complications were subdivided into stoma hyper-
granulation, stoma redundant tissue and other soft tissue complications. The incidence of
Table 5. Complication-related interventions.
Authors (years) Implant type/
Level of
amputation
Oral
antibiotics
(%)
Parenteral
antibiotics
(%)
Surgical debridement (%) (% of
total: infection,
hypergranulation, stoma
redundant tissue, other)
Explantation (%) (% of
total: infection,
loosening, bone/implant
fracture, other)
Successful re-
implantation (% of
explantation)
Fracture treatment (%
of fractures)
(conservative/surgical)
Transfemoral
Tillander et al.
(2017) [73]
Screw ? ? ? 17 (63: inf., 38: ?) 6 (100% of infection
explantations) 
?
Sullivan et al.
(2003) [72]
Screw ? ? ? 18 (100: inf.) ? ?
Al Muderis et al.
(2017) [70]
Press-fit 48 (all grade
1 cases)
10 (all grade
2 cases)
29 (100: redund.) 0 NA NA
Al Muderis et al.
(2016) [61]
Press-fit 27 1 22 (27: inf., 73: redund.) 3 (33: loose., 67: intr.
device break.)
100 100: surgical
Al Muderis et al.
(2016) [43]
Press-fit 26 10 20 (30:inf., 70: redund.) 4 (50: loose., 50: intr.
device break.)
100 100: surgical
Aschoff et al.
(2016) [47]
Press-fit ? ? ? (6 of total TF+TT (100:
redund.))
6 (80: inf., 20: device
break.)
Unknown (38% of
total explantations
TF+TT)
100: surgical
Juhnke et al.
(cohort 1) (2015)
[50]
Press-fit ? ? 77 (100:inf.) 13 (100: inf.) 50 100: surgical
Juhnke et al.
(cohort 2) (2015)
[50]
Press-fit ? ? 8 (33: hyperg., 33: redund., 33:
ilizarov treatment)
3 (100: loose.) 100 100: surgical
Juhnke et al.
(2015) [49]
Press-fit ? ? ? 6 (unknown) 50 100: surgical
McGough et al.
(2017) [51]
Compress ? ? 9 (100: redund.) 9 (100: bone fract.) 100 50: surgical in
combination with
implant revision, 50:
awaiting revision
Authors (years) Implant type/
Level of
amputation
Oral
antibiotics
(%)
Parenteral
antibiotics
(%)
Surgical debridement (%) (% of
total: infection,
hypergranulation, stoma
redundant tissue, other)
Explantation (%) (% of
total: infection,
loosening, bone/implant
fracture, other)
Successful re-
implantation (% of
explantation)
Fracture treatment (%
of fractures)
(conservative/surgical)
Transtibial
Aschoff et al.
(2016) [47]
Press-fit ? ? ? (6 of total TF+TT (100:
redund.))
43 (33: inf., 67: loose.) Unknown (38% of
total explantations
TF+TT)
?
Juhnke et al.
(2015) [49]
Press-fit ? ? ? 57 (unknown) 25 ?
Upper extremity
Li et al. (2017)
[71]
Screw (Mixed
upper
extremity)
? ? ? TH: 19 (67: loose., 33:
glenohumeral
osteoarthritis) TR: ?,
Thumb: ?
TH: 33 ?
Tsikandylakis
et al. (2014) [75]
Screw (TH) 22 ? 11 (100: inf.) 17 (67: loose., 33:
glenohumeral
osteoarthritis)
33 ?
Tillander et al.
(2010) [74]
Screw (Mixed
upper/lower
extremity)
? ? ? 14 (60: Deep inf. (TF), 20:
loose (TF), 20: Chronic
skin inf. (unknown))
40 ?
TF = Transfemoral, TT = Transtibial, TH = Transhumeral, Inf. = Infection, Redund. = Stoma rendundant tissue, Loose.: Implant loosening, Intr. = Intramedullary
device, Fract. = Fracture, Break.: Breakage, Hypergr. = Hypergranulation tissue.
 No data on succesfull reimplantation of individuals with explantation with unknown reason.
https://doi.org/10.1371/journal.pone.0201821.t005
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stoma hypergranulation and redundant tissue was reported in five of the 15 cohorts (33%)
with other soft tissue complications also being reported in the cohort assessed by Juhnke et al.
(Table 4).[43, 50, 51, 61, 75]
Stoma hypergranulation occurred in 44% and 3–20% of individuals treated with screw and
press-fit implants, respectively, and was not reported in individuals treated with the Compress
implant. Stoma redundant tissue was not reported in the cohorts of individuals treated with
screw implants, but occurred in 3–16% and 9% of individuals treated with press-fit and the
Compress implant respectively. All cases of stoma hypergranulation and stoma redundant tis-
sue reported on in individuals treated with press-fit or Compress implants occurred in individ-
uals with transfemoral amputation.
Soft tissue complications in individuals with upper extremity amputation were reported in
one cohort, with a rate of stoma hypergranulation of 44% in individuals with transhumeral
amputation treated with screw implants.[75] No soft tissue complications were reported in
individuals with transtibial amputation.
Systemic events and death. No cohorts described systemic events such as pulmonary
embolism and myocardial infarction and no device-related deaths have been reported.
Antibiotics treatment. In four of the 15 cohorts (27%), the use of antibiotics was reported:
one in screw implants and three in press-fit implants.[43, 61, 70, 75] Oral antibiotics were used
in 26–48% of individuals with transfemoral amputation treated with press-fit implants and in
22% of individuals with transhumeral amputation treated with screw implants. Parenteral anti-
biotics were used in 1–10% of individuals with transfemoral amputation treated with press-fit
implants.
No clear overview of the use of antibiotics for the treatment of infections was provided in
the other cohorts.
Surgical debridement. The need for surgical debridement was subdivided according to
the indication as follows: infection, hypergranulation, stoma redundant tissue or other and
was reported in nine of the 15 cohorts (60%), seven of which were cohorts of individuals
treated with press-fit implants.[43, 47, 50, 51, 61, 70, 75] The incidence of surgical revision was
11% and 9% in individuals treated with a screw and Compress implant respectively and ranged
from 6–77% in individuals treated with press-fit implants. A revision rate of 77%, all due to
infection, was reported in the first cohort described by Juhnke et al. [50] consisting of individ-
uals with transfemoral amputation treated with first-generation press-fit implants. The revi-
sion rate was 8% in the second cohort after iteration of the surgical technique and implant
design, none of which were due to infection. The main overall reasons for surgical revision in
all cohorts were stoma redundant tissue and infection.
Explantation and re-implantation. The incidence of explantation was described in all
cohorts and ranged from 14–19% in individuals treated with a screw implant,[71–75] from
0–57% in individuals treated with a press-fit implant [43, 47, 49, 50, 61, 70] and was 9% in indi-
viduals treated with the Compress implant.[51]
Assessment of the level of amputation revealed an explantation rate of 17–18%, 0–13% and
9% in individuals with transfemoral amputation treated with a screw, press-fit or Compress
implant, respectively. Two reasons for the explantation of transfemoral implants were intrame-
dullary device breakage, which only occurred in the press-fit implants; and bone fracture,
which only occurred in the Compress implant. Implant loosening and infection were other
reasons for explantation of transfemoral implants and occurred in both the screw and press-fit
implants but not the Compress implant. The rate of explantation was much higher in individu-
als with transtibial amputation ranging from 42–57%, with Aschoff et al.[47] reporting high
rates of implant loosening. All these individuals were treated with press-fit implants. The
explantation rate was 17–19% in individuals with transhumeral amputation treated with screw
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implants. An explantation rate of 14% was reported in the cohort evaluated by Tillander et al.
[74] comprising a combination of individuals, all of which being individuals with transfemoral
amputation treated with screw implants.
The incidence of re-implantation was reported in 13 of the 15 cohorts (87%); it was per-
formed successfully in 100% of individuals treated with the Compress implant and in 6–40%
and 25–100% of the cohorts of individuals treated with screw and press-fit implants, respec-
tively.[43, 47, 49–51, 61, 70, 71, 73–75] Only Tillander et al. [73] reported on re-implantation
in individuals with transfemoral amputation treated with screw implants, being succesfull in
6% of individuals all of which explanted due to infection. They did not report on re-implanta-
tion rates for the individuals treated with explantation with other etiologies. Thus successful
re-implantation rates were unclear in individuals with transfemoral amputation treated with a
screw implants while being successful in 50–100% and 100% of individuals with transfemoral
amputation treated with a press-fit and Compress implant respectively. Re-implantation was
successful in 25% of individuals with transtibial amputation in the cohort described by Juhnke
et al.,[49] while the exact rate of successful re-implantation was not clearly reported in the
cohort reported by Aschoff et al.[47] Re-implantation was successful in 33% of individuals
with transhumeral amputation, and Tillander et al. [74] reported a successful re-implantation
rate of 40% in their cohort of individuals with an upper- and lower-extremity amputation
treated with screw-fit implants.
Peri-prosthetic fracture treatment. The occurrence of peri-prosthetic fracture treatment
was described in seven of the 15 cohorts (47%); of which six cohorts involving individuals with
transfemoral amputations treated with press-fit implants and one involving individuals treated
with the Compress implant.[43, 47, 49–51, 61] In these cohorts, all peri-prosthetic bone frac-
tures were treated surgically and treatment was combined with an implant revision in the
cohort of individuals treated with the Compress implant.
Discussion
This is the first study to provide a complete and detailed overview of device-related complica-
tions in both individuals with lower and/or upper extremity amputation treated with screw,
press-fit or other types of bone-anchored prostheses, while also providing an overview of com-
plication-related interventions.
The occurrence of explantation of implants was the only outcome reported in all cohorts, fol-
lowed by re-implantation (87%), infection (73%) and implant loosening (60%). For the purpose
of comparison, complications rates reported by Branemark et al. [41], which was excluded due
to complete overlap with Tillander et al. [73], that did not come to light in the other cohorts will
be included in the discussion (Total infection 67% (grade 1–2: 58%, grade 3: 6%, grade 4: 2%),
device fracture: 8% (all of which abutment), implant loosening: 6%, explantation 8%). a) Explan-
tation rates seemed to vary greatly when comparing different implants (screw: 8–19%, press-fit:
0–57%, Compress: 9%), but due to the high explantation rates of transtibial implants (43–57%),
all of which were press-fit, these rates provide a biased representation of the outcome. If only
explantation rates of transfemoral implants are compared, press-fit implants seem to be less fre-
quently explanted than screw-fit implants (0–13% vs 8–18%) with a similar rate of explantation
of the Compress implant (9%), being the only implant that had to be explanted due to a bone
fracture. Explantation rates in individuals with transhumeral amputation treated with screw
implants ranged from 17–19%. The article by Jonsson et al.[68], which was excluded due to com-
plete overlapping data with Li et al.[71], reported in more detail the explantation rates in individ-
uals with transradial and thumb implants treated with screw implants, being 10% and 30%
respectively. b) Re-implantation was typically more successful in individuals treated with a press-
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fit or Compress implant, especially in individuals with transfemoral amputation (Press-fit: 50–
100%, Compress: 100%, screw: 6%); however these rates may also be biased, as only one Com-
press implant was re-implanted and it is also possible that re-implantation was attempted more
often in certain subgroups. The article by Tillander et al.[73] reported on a successful re-implan-
tation rate of 6% in individuals that had their implant explanted due to infection, only they did
not report on re-implantation rates of the individuals that underwent explantation on other
accounts. c) Total infection rates varied substantially between studies, with no infections occur-
ring in the small cohort treated with the Compress implant and seemingly showing a favorable
trend of implant infections (Grade 4) for the screw over the press-fit implant (screw: 2–11%,
press-fit: 0–29%); although these numbers, again, are greatly affected by transtibial implants in
which there is less expertise. When comparing implant infections between transfemoral screw
and press-fit implants (screw: 2–11%, press-fit: 0–3%) there is a considerable difference, and
when looking at amputation level (transtibial (press-fit): 29%, upper extremity (screw): 11%) it is
clear that there are high rates of implant infections in transtibial implants. d) Again, when exam-
ining implant loosening and comparing implants (screw: 3–23%, press-fit: 0–29%, Compress:
0%) a biased representation is created due to the high rate of complications in individuals with a
transtibial and upper extremity amputation. When only comparing rates between individuals
with a transfemoral amputation, the rates seem to be slightly lower in press-fit implants (screw:
6%, press-fit: 0–3%), with increasing rates in upper extremity screw implants (Thumb: 23%,
transhumeral 13%) and very high rates of implant loosening in individuals with press-fit transti-
bial implants (29%).
Other noteworthy findings concern the incidence of device breakage and surgical revision;
a) Device breakages occurred at rates of 0% in the small Compress implant cohort and 8–45%
and 0–31% in individuals treated with screw and press fit implants respectively, but were
mainly due to breakage of external replaceable parts of the prosthetic system, except for the
individuals with transradial implants (27% fixture breakage). Breakage of the intramedullary
device was rarely observed in individuals with transfemoral implants, with an incidence of 0%
in screw transfemoral implants and 1% in press-fit transfemoral implants. b) The need for sur-
gical revision varies greatly between all cohorts (8–77%), and has only been reported in 60% of
cohorts. Infection and stoma redundant tissue appear to be the main reasons for surgical revi-
sion, and these rates could be considerably affected by iterations of the implant design and the
surgical technique.[50] The treatment of infection with, for instance, antibiotics, and the
occurrence of soft tissue complications were greatly under-reported by the included articles,
even though multiple articles concluded that infection and soft tissue complications were the
most commonly encountered problems in individuals treated with bone-anchored prosthetics.
[47, 49, 50, 53]
To help interpret the complication rate of bone-anchored prostheses, a head-on compari-
son with the complication rates in primary total hip arthroplasty (THA), which is considered
standard orthopedic care, with acceptable complication rates has been performed.[76] Gund-
toft reported a cumulative 5-year incidence of prosthetic joint infections in 29.077 individuals
treated with 32.896 primary THA’s of 1%.[77] These deep infections or prosthetic joint infec-
tions are equivalent to the grade 4 infections mentioned above and, especially in the case of
press-fit transfemoral bone-anchored implants, show potentially similar results (0–3%). The
systematic reviews by van Eck et al. [54], Hebert et al. [55] and Al Muderis et al [56] had an
overlapping research question with this review and briefly reported on the complications of
bone-anchored prostheses. Of the 12 articles included in this systematic review, only two, [72,
74] six [43, 50, 61, 70, 72, 74] and two [72, 74] were included by van Eck et al., Hebert et al.
and Al Muderis et al., respectively, to evaluate complication incidence. The cause of this differ-
ence is that we excluded articles with complete overlap and included participants with an
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upper extremity amputation. It was not possible to compare our result with the above- men-
tioned reviews because van Eck et al. did not stratify the extracted data, Hebert et al. only pre-
sented the data per included article but failed to present overall complication ranges and Al
Muderis et al. presented only non-detailed descriptive data.
Strengths and limitations
A number of factors may have led to distortion of the findings of this review. First, most arti-
cles only reported limited complications, with no article providing a complete review of all
possibly occurring complications. Explantation was the only complication mentioned in all
articles. Second, despite our efforts to prevent overlap, there most likely was partial overlap of
patient data in some of the included studies, due to an overlap in the periods of inclusion of
individuals (Fig 2); which can lead to duplicate data and may affect outcomes. Third, in many
of the included studies, it was unclear how the complications were reported [47, 49, 51, 71],
and the study by Tsikandylakis et al. [75] was the only one that reported on the type of exam-
iner that registered complications at follow-up. In most studies, it was unclear whether the
complications were collected in specific databases, by investigating electronic patient files or
by acquiring information from general practitioners or other hospitals. Fourth, a certain type
of selection bias might have occurred, for instance, in the article by Tillander et al. [74], which
included individuals attending the clinic for scheduled or emergency visits. Fifth, all included
articles were cohort studies, prospective or even retrospective, also giving rise to questions
regarding the methodological quality. Sixth, given the small number of individuals included in
every study and the varying number of studies reporting certain outcomes, the overall compli-
cation rates could be greatly influenced by single outliers. Seventh, the learning curve for the
treatment and adaptation of technique and design can also affect complication rates. The arti-
cle by Juhnke et al. [50] reported a very high incidence of surgical re-intervention in its first
cohort, which decreased substantially as a result of iterations of the device design and surgical
technique. The article by Hagberg et al. [42], which was excluded due to complete overlap with
Tillander et al. [73], also stated that most failures occurred in the early group of individuals
that was not treated with a standardized rehabilitation protocol. Eighth, a number of factors
may have led to the underestimation of certain complications. It can be suspected that minor
complications are likely to be treated by the general practitioner, possibly resulting in an un-
derestimation in the report. Another reason for the possible underestimation of complications
is the presence of multiple studies that did not clearly report the occurrence of infections, with
some only reporting major complications, such as high grade infections (Grade 3–4), that led
to surgical interventions.[47, 49, 50] Complications are often patient-reported, which can also
result in an underestimation. Some form of publication bias may have also led to an underesti-
mation of overall complications found in this review, as it is possible that studies with negative
outcomes might have not been published. Ninth, it is important to note that conclusions
drawn should be interpreted as originating from included studies with a generally weak nature
of quality. Assessing the methodological quality of articles reporting complications can lead to
difficulties due to the lack of a gold standard classification system to establish complications
after bone-anchored prostheses surgery or a consensus regarding specific data collection meth-
ods. Other aspects ranked by critical appraisal tools, such as controlling for confounders and
the level of blinding, can rarely be avoided because complication data are mostly collected dur-
ing daily clinical care.
The first and most important strength of this review is that subgroup analyses were per-
formed regarding the implant type and level of amputation, resulting in improved clinical util-
ity. Thus, when more data are available in the future, it might be possible to supply targeted
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advice regarding the choice of implant type in terms of the level of amputation. We also clari-
fied that, given the way data have been published to date, it is not possible to stratify complica-
tions as short- , mid- or long-term complications. More studies with fixed follow-up periods,
such as the study by Branemark et al., [41] are necessary to clarify this point. Complications
have been well-defined in most studies and regular follow-ups with substantial overlap
between different articles, but these follow-ups were not used as specific time points for report-
ing complications in these publications. A second strong point is that we have given a clear
insight in the great amount of patient data overlap through the Gantt chart depicted in Fig 2.
To correct for the effect of the overlapping cohorts and duplicate data, we aimed to perform an
individual patient data (IPD) meta-analysis. Rather than extracting summary data from the
study publications, we searched for the original research data directly from the researchers to
exclude any duplicates. Performing this IPD meta-analysis was not possible because the app-
roached researchers were not able to share their original data. A third strong point is the high
level of agreement between the two reviewers about ratings of methodological quality.
Recommendation for future research
As mentioned above, there was no clear consensus in the studies included regarding which com-
plications were reported. In future research, it would be beneficial if all studies would report the
same complications in the same manner. A core set should be formulated to provide a represen-
tation of the most important complications that should be reported. The content of this core set
could be as follows: infection, soft tissue complications, bone fracture, device breakages, implant
loosening, explantation, surgical revision, antibiotic use, re-implantation, systemic events and
death and uneventful course (Table 4).[43, 50, 61] Within this core set, it would also be beneficial
to have strict follow-up times (for example 1, 2, 3, 5 and 10 years). When reporting certain com-
plications, it would be beneficial to follow a certain classification system, such as, for example,
the classification system for infection as proposed by Al Muderis et al. Table 1.[61] Furthermore,
to interpret the current data in an improved fashion, an IPD meta-analyses is suggested for
future research. To facilitate the process of data collection, it is advisable to construct a central
database in which all data are stored that follows the core set of above-mentioned complications.
We were not able to perform a meta-analysis due to the heterogeneity of the data in terms of out-
comes and follow-up intervals. To facilitate a meta-analysis in the future we suggest the following
fixed follow-up periods: one, two, five, 10- and 20-year post-operative follow-ups.
Conclusion
In conclusion, this systematic revealed that in individuals treated with a transfemoral implant
the incidence of major complications such as implant infection, implant loosening and explan-
tation was lower in users of a press-fit implant compared to a screw implant. Individuals treated
with a transtibial or upper extremity implant and compress implant were underreported, pre-
cluding definitive conclusions. The current data revealed that the complication rates encoun-
tered in these subgroups of individuals exceed what is deemed acceptable for regular orthopedic
interventions. In general, minor complications are most common, such as complications or
infections of the soft tissues, which may be greatly affected by the learning curve, implant design
and surgical technique, and breakage of external replaceable parts of the implant.
To improve future treatment and research, it will be necessary to formulate a core set of
complications that should be reported at fixed time points, as well as to follow a classification
system that results in clear and unequivocal data and research. This review could also help pro-
fessionals and patients in the choice of implant type with respect to the amputation level.
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However, it should be kept in mind that our conclusions are based on articles of low methodo-
logical quality.
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